Target intelligence / Profile preview

Long intergenic non-protein coding RNA 399 (LINC00399)

Target
LINC00399
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 399 (LINC00399) is a non-coding RNA transcript located at 13q33.3 in the human genome[1][4][7]. As a member of the lincRNA class, it exceeds 200 nucleotides in length and is transcribed from a region not overlapping with known protein-coding genes[2][5]. lincRNAs are known for roles in chromatin architecture remodeling, transcriptional regulation, and, more generally, fine-tuning gene expression with tissue specificity[2][5]. However, the functional role, disease association, and clinical relevance of LINC00399 itself have not been specifically characterized in the current literature or disease databases. No interacting drugs, biomarker roles, or direct disease associations are reported for this RNA.

Other names
TCONS_00021596long intergenic non-protein coding RNA 399LINC00399
02

Mechanism of action

Not applicable (no drugs or small molecules known to modulate LINC00399 specifically)

03

Biological functions

Chromatin remodelingGene expression regulationRNA stabilizationPossible enhancer-associated activityNo specific function attributed to LINC00399 itself by current sources; these functions are general for lincRNAs.
04

Disease associations

None specifically assigned to LINC00399lincRNAs broadly have roles in epigenetic regulation and have been implicated in disease, cancer, and cellular differentiation, but no evidence describes a role for LINC00399 in a particular disease
05

Safety considerations

None described; therapeutic manipulation of lincRNAs in general faces challenges such as off-target effects and biological redundancy, but no LINC00399-specific issues have been noted
06

Interacting drugs

None reported
07

Biomarkers

None specifically attributed

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 399 (LINC00399).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 399 (LINC00399).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call